Gastrointestinal Cancer

Latest News

colon cancer
Using ctDNA MRD Monitoring During Active Metastatic CRC Treatment

November 22nd 2023

Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, shares her real-world experience with circulating-tumor-DNA monitoring in the colorectal cancer setting.

crc
‘More Isn’t Always Better’ With Adjuvant Chemotherapy in Colon Cancer

November 17th 2023

FDA
Pembrolizumab Is Approved for Patients With HER2– Gastric/GEJ Adenocarcinoma

November 16th 2023

FDA
New Companion Diagnostic Is Approved to Aid In Gastric Cancer Decision Making

November 15th 2023

FDA
FDA Revisits Pembrolizumab’s Gastric Cancer Indication

November 12th 2023

Latest CME Events & Activities

Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

View More

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Updates in Myelodysplastic Syndromes

View More

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

More News

© 2023 MJH Life Sciences

All rights reserved.